853 ACTM-838: a Microbial-Based Immunotherapy That Delivers Combination IL-15 + Engineered STING to Tumor-Resident APCs after IV Dosing in T-cell Excluded Solid Tumors
JOURNAL FOR IMMUNOTHERAPY OF CANCER（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined